{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:07:20Z","timestamp":1791086840707,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.leukres.2010.07.031","type":"journal-article","created":{"date-parts":[[2010,8,20]],"date-time":"2010-08-20T10:32:34Z","timestamp":1282300354000},"page":"608-613","source":"Crossref","is-referenced-by-count":33,"title":["Myeloid blastic transformation of myeloproliferative neoplasms\u2014A review of 112 cases"],"prefix":"10.1016","volume":"35","author":[{"given":"Syed J.","family":"Noor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory E.","family":"Wilding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie A.","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice","family":"Barcos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila N.J.","family":"Sait","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AnneMarie W.","family":"Block","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunice S.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meir","family":"Wetzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2010.07.031_bib0005","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.hoc.2009.04.002","article-title":"The myeloproliferative neoplasms: insights into molecular pathogenesis and changes in WHO classification and criteria for diagnosis","volume":"23","author":"Anastasi","year":"2009","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.leukres.2010.07.031_bib0010","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1002\/cncr.21297","article-title":"Leukemic transformation of polycythemia vera: a single center study of 23 patients","volume":"104","author":"Passamonti","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2010.07.031_bib0015","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000204873","article-title":"Acute transformation in nonleukemic chronic myeloproliferative disorders: actuarial probability and main characteristics in a series of 218 patients","volume":"85","author":"Cervantes","year":"1991","journal-title":"Acta Haematol"},{"key":"10.1016\/j.leukres.2010.07.031_bib0020","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1182\/blood-2004-07-2864","article-title":"Leukemic transformation in myelofibrosis with myeloid metaplasia: a single-institution experience with 91 cases","volume":"105","author":"Mesa","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2010.07.031_bib0025","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(05)74230-6","article-title":"Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders","volume":"365","author":"Baxter","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.leukres.2010.07.031_bib0030","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nature03546","article-title":"A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera","volume":"434","author":"James","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2010.07.031_bib0035","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1056\/NEJMoa051113","article-title":"A gain-of-function mutation of JAK2 in myeloproliferative disorders","volume":"352","author":"Kralovics","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.leukres.2010.07.031_bib0040","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","article-title":"Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis","volume":"7","author":"Levine","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.leukres.2010.07.031_bib0045","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1182\/blood-2006-02-002030","article-title":"JAK2V617F expression in murine hematopoietic cells leads to MPD mimicking human PV with secondary myelofibrosis","volume":"108","author":"Lacout","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2010.07.031_bib0050","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1182\/blood-2005-12-4824","article-title":"Expression of Jak2V617F causes a polycythemia vera-like disease with associated myelofibrosis in a murine bone marrow transplant model","volume":"107","author":"Wernig","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2010.07.031_bib0055","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/jnci\/djp216","article-title":"JAK2 inhibitors: not the next imatinib but researchers see other possibilities","volume":"101","author":"Garber","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.leukres.2010.07.031_bib0060","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1182\/blood-2005-05-1800","article-title":"JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome-negative CML, and megakaryocytic leukemia","volume":"106","author":"Jelinek","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2010.07.031_bib0065","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1182\/blood-2005-12-013748","article-title":"Mutation of JAK2 in the myeloproliferative disorders: timing, clonality studies, cytogenetic associations, and role in leukemic transformation","volume":"108","author":"Campbell","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2010.07.031_bib0070","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1038\/sj.leu.2404707","article-title":"JAK2V617F as progression marker in CMPD and as cooperative mutation in AML with trisomy 8 and t(8;21): a comparative study on 1103 CMPD and 269 AML cases","volume":"21","author":"Schnittger","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2010.07.031_bib0075","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.leukres.2007.11.004","article-title":"Disappearance of JAK2 V617F mutation in a rapid leukemic transformed essential thrombocythemia patient","volume":"32","author":"Hsiao","year":"2008","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2010.07.031_bib0080","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1182\/blood-2008-02-138230","article-title":"The natural history and treatment outcome of blast phase BCR-ABL-myeloproliferative neoplasms","volume":"112","author":"Tam","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2010.07.031_bib0085","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1182\/blood-2006-04-014712","article-title":"JAK2T875N is a novel activating mutation that results in myeloproliferative disease with features of megakaryoblastic leukemia in a murine bone marrow transplantation model","volume":"108","author":"Mercher","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2010.07.031_bib0090","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1371\/journal.pmed.0030270","article-title":"MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia","volume":"3","author":"Pikman","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.leukres.2010.07.031_bib0095","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1182\/blood-2004-09-3426","article-title":"Acute leukemia in polycythemia vera: an analysis of 1638 patients enrolled in a prospective observational study","volume":"105","author":"Finazzi","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2010.07.031_bib0100","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.leukres.2006.12.002","volume":"31","author":"Mesa","year":"2007","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2010.07.031_bib0105","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1200\/JCO.2003.04.036","article-title":"Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia","volume":"21","author":"Cheson","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2010.07.031_bib0110","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00262-008-0567-5","article-title":"Targeting 11q23 positive acute leukemia cells with high molecular weight-melanoma associated antigen-specific monoclonal antibodies","volume":"58","author":"Drake","year":"2009","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.leukres.2010.07.031_bib0115","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.leukres.2009.07.006","article-title":"Implementation of standardized international karyotype scoring practices is needed to provide uniform and systematic evaluation for patients with myelodysplastic syndrome using IPSS criteria: an international working group on MDS cytogenetics study","volume":"34","author":"Chun","year":"2010","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2010.07.031_bib0120","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0165-4608(84)90025-6","article-title":"Cytogenetic studies on acute nonlymphocytic leukemias following polycythemia vera","volume":"11","author":"Berger","year":"1984","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.leukres.2010.07.031_bib0125","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/ajh.2830220206","article-title":"Trisomy 1q in polycythemia vera and its relation to disease transition","volume":"22","author":"Swolin","year":"1986","journal-title":"Am J Hematol"},{"key":"10.1016\/j.leukres.2010.07.031_bib0130","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1002\/1097-0142(19871201)60:11<2654::AID-CNCR2820601114>3.0.CO;2-Q","article-title":"Myeloproliferative disorders terminating in acute megakaryoblastic leukemia with chromosome 3q26 abnormality","volume":"60","author":"Akahoshi","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2010.07.031_bib0135","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0165-4608(87)90102-6","article-title":"Isochromosome 17q in a case of myelofibrosis with myeloid metaplasia terminating in blastic transformation","volume":"24","author":"Nakamura","year":"1987","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.leukres.2010.07.031_bib0140","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0165-4608(88)90102-1","article-title":"Idiopathic myelofibrosis in blast transformation with 4;12 and 5;12 translocations and a 7q deletion","volume":"30","author":"Przepiorka","year":"1988","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.leukres.2010.07.031_bib0145","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/1097-0142(19900401)65:7<1538::AID-CNCR2820650715>3.0.CO;2-3","article-title":"Blastic transformation in essential thrombocythemia. In vitro differentiation of blast cells into granulocytic, erythroid, and megakaryocytic lineages","volume":"65","author":"Kimura","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2010.07.031_bib0150","first-page":"719","article-title":"Primary myelofibrosis in children: report of 4 cases","volume":"89","author":"Wang","year":"1990","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.leukres.2010.07.031_bib0155","first-page":"868","article-title":"Acute megakaryoblastic leukemia developing 11 years after diagnosis of essential thrombocythemia","volume":"32","author":"Miyoshi","year":"1991","journal-title":"Rinsho Ketsueki"},{"key":"10.1016\/j.leukres.2010.07.031_bib0160","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3109\/10428199309148545","article-title":"Progression of essential thrombocythemia to blastic crisis via idiopathic myelofibrosis","volume":"9","author":"Emilia","year":"1993","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.leukres.2010.07.031_bib0165","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/ajh.2830440111","article-title":"CD7, CD34-positive stem cell leukemia arising in agnogenic myeloid metaplasia","volume":"44","author":"Tasaka","year":"1993","journal-title":"Am J Hematol"},{"key":"10.1016\/j.leukres.2010.07.031_bib0170","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000204260","article-title":"Essential thrombocythemia terminating in acute leukemia with minimal myeloid differentiation\u2014a brief review of recent literature","volume":"91","author":"Shibata","year":"1994","journal-title":"Acta Haematol"},{"key":"10.1016\/j.leukres.2010.07.031_bib0175","first-page":"434","article-title":"Trisomy 13 in a case of myelofibrosis with myeloid metaplasia with early blastic transformation","volume":"80","author":"Ferrara","year":"1995","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2010.07.031_bib0180","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3109\/10428199509112210","article-title":"Leukemic transformation of primary myelofibrosis: immunophenotype, genotype and growth characteristics of blast cells","volume":"19","author":"Kimura","year":"1995","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.leukres.2010.07.031_bib0185","first-page":"1210","article-title":"Essential thrombocythemia in transformation to smouldering megakaryoblastic leukemia with myelofibrosis","volume":"36","author":"Uesugi","year":"1995","journal-title":"Rinsho Ketsueki"},{"key":"10.1016\/j.leukres.2010.07.031_bib0190","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.4065\/74.12.1233","article-title":"Hypercalcemia complicating leukemic transformation of agnogenic myeloid metaplasia-myelofibrosis","volume":"74","author":"Kumar","year":"1999","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.leukres.2010.07.031_bib0195","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/jjco\/hyd084","article-title":"Essential thrombocythemia transformed to acute myelogenous leukemia with t(3;17)(p24; q12), del(5)(q13q34) after treatment with carboquone and hydroxyurea","volume":"30","author":"Tabata","year":"2000","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.leukres.2010.07.031_bib0200","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0165-4608(02)00554-X","article-title":"Frequency of structural abnormalities of the long arm of chromosome 12 in myelofibrosis with myeloid metaplasia","volume":"137","author":"Andrieux","year":"2002","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.leukres.2010.07.031_bib0205","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1034\/j.1600-0609.2002.01601.x","article-title":"Leukemic transformation with trisomy 8 in essential thrombocythemia: a report of four cases","volume":"68","author":"Hirose","year":"2002","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.leukres.2010.07.031_bib0210","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1046\/j.0902-4441.2003.00139.x","article-title":"Spontaneous evolution of essential thrombocythaemia into acute megakaryoblastic leukaemia with trisomy 8, trisomy 21 and cutaneous involvement","volume":"71","author":"Paolini","year":"2003","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.leukres.2010.07.031_bib0215","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/ajh.20164","article-title":"Essential thrombocythemia terminating in pure erythroleukemia","volume":"77","author":"Kreft","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1016\/j.leukres.2010.07.031_bib0220","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1001\/archinte.165.22.2651","article-title":"Long-term outcome of 231 patients with essential thrombocythemia: prognostic factors for thrombosis, bleeding, myelofibrosis, and leukemia","volume":"165","author":"Chim","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.leukres.2010.07.031_bib0225","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.leukres.2005.03.011","article-title":"De novo appearance of der(1;7)(q10;p10) is associated with leukemic transformation and unfavorable prognosis in essential thrombocythemia","volume":"29","author":"Hsiao","year":"2005","journal-title":"Leukemia Res"},{"key":"10.1016\/j.leukres.2010.07.031_bib0230","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/ajh.20254","article-title":"Long-term follow-up of a patient with idiopathic myelofibrosis associated with chromosome 11 and 13 abnormalities","volume":"78","author":"Toubai","year":"2005","journal-title":"Am J Hematol"},{"key":"10.1016\/j.leukres.2010.07.031_bib0235","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/sj.leu.2405093","article-title":"NPM1-mutated acute myeloid leukaemia occurring in JAK2-V617F+ primary myelofibrosis: de-novo origin?","volume":"22","author":"Pasqualucci","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2010.07.031_bib0240","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00277-008-0461-4","article-title":"Therapy-related patterns of cytogenetic abnormalities in acute myeloid leukemia and myelodysplastic syndrome post polycythemia vera: single center experience and review of literature","volume":"87","author":"Swolin","year":"2008","journal-title":"Ann Hematol"},{"key":"10.1016\/j.leukres.2010.07.031_bib0245","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.cancergencyto.2007.12.016","article-title":"Association of inv(3)(q21q26) with essential thrombocythemia in transformation","volume":"184","author":"Villalon","year":"2008","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.leukres.2010.07.031_bib0250","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/j.leukres.2008.03.015","article-title":"Decreased JAK2 V617F allele burden level in a myelofibrosis with myeloid metaplasia patient with leukemic transformation","volume":"32","author":"Wu","year":"2008","journal-title":"Leukemia Res"},{"key":"10.1016\/j.leukres.2010.07.031_bib0255","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1056\/NEJM198102193040801","article-title":"Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil therapy","volume":"304","author":"Berk","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1016\/j.leukres.2010.07.031_bib0260","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s11739-009-0284-x","article-title":"Essential thrombocythemia: past and present","volume":"4","author":"Fabris","year":"2009","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.leukres.2010.07.031_bib0265","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/sj.leu.2404500","article-title":"Risk stratification for survival and leukemic transformation in essential thrombocythemia: a single institutional study of 605 patients","volume":"21","author":"Gangat","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2010.07.031_bib0270","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/j.seminhematol.2004.02.006","article-title":"The leukemia controversy in myeloproliferative disorders: is it a natural progression of disease, a secondary sequela of therapy, or a combination of both?","volume":"41","author":"Barbui","year":"2004","journal-title":"Semin Hematol"},{"key":"10.1016\/j.leukres.2010.07.031_bib0275","doi-asserted-by":"crossref","first-page":"5587","DOI":"10.1200\/JCO.2009.22.8833","article-title":"Dynamic model for predicting death within 12 months in patients with primary or post-polycythemia vera\/essential thrombocythemia myelofibrosis","volume":"27","author":"Tam","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2010.07.031_bib0280","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2009-09-245837","article-title":"A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)","volume":"115","author":"Passamonti","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2010.07.031_bib0285","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1158\/0008-5472.CAN-09-3783","article-title":"Genetic analysis of transforming events that convert chronic myeloproliferative neoplasms to leukemias","volume":"70","author":"Abdel-Wahab","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2010.07.031_bib0290","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1182\/blood.V114.22.631.631","article-title":"Significant activity of the JAK2 inhibitor, INCB018424 in patients with secondary, post-myeloproliferative disorder (MPD) acute myeloid leukemia (sAML): results of an exploratory phase II study","volume":"114","author":"Ravandi","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2010.07.031_bib0295","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1200\/JCO.2008.21.3264","article-title":"Targeting signal transducer and activator of transcription signaling pathway in leukemias","volume":"27","author":"Benekli","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2010.07.031_bib0300","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1600-0609.2009.01224.x","article-title":"Conventional cytogenetics in myelofibrosis: literature review and discussion","volume":"82","author":"Hussein","year":"2009","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.leukres.2010.07.031_bib0305","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1600-0609.2009.01392.x","article-title":"Chromosome 1 abnormalities in myeloid malignancies: a literature survey and karyotype-phenotype associations","volume":"84","author":"Caramazza","year":"2010","journal-title":"Eur J Haematol"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212610003747?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212610003747?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T18:50:26Z","timestamp":1591815026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212610003747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":61,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0145212610003747"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2010.07.031","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}